PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $708,172 | +67667.7% | 23,083 | -16.2% | 0.00% | -50.0% |
| Q4 2022 | $1,045 | -99.9% | 27,544 | -22.3% | 0.01% | -46.7% |
| Q3 2022 | $1,835,000 | -13.4% | 35,460 | -9.3% | 0.02% | -11.8% |
| Q2 2022 | $2,120,000 | -27.3% | 39,110 | +0.8% | 0.02% | -19.0% |
| Q1 2022 | $2,918,000 | +24.6% | 38,785 | +2.5% | 0.02% | +23.5% |
| Q4 2021 | $2,341,000 | +9.4% | 37,848 | -6.9% | 0.02% | +30.8% |
| Q3 2021 | $2,139,000 | -5.8% | 40,653 | -2.1% | 0.01% | -7.1% |
| Q2 2021 | $2,270,000 | -21.3% | 41,536 | -6.8% | 0.01% | -17.6% |
| Q1 2021 | $2,884,000 | -7.6% | 44,588 | -3.1% | 0.02% | -15.0% |
| Q4 2020 | $3,122,000 | +25.0% | 46,008 | +2.2% | 0.02% | +11.1% |
| Q3 2020 | $2,498,000 | +2.7% | 45,029 | +0.4% | 0.02% | -5.3% |
| Q2 2020 | $2,432,000 | +49.5% | 44,847 | +9.7% | 0.02% | +26.7% |
| Q1 2020 | $1,627,000 | -4.0% | 40,887 | +3.8% | 0.02% | +15.4% |
| Q4 2019 | $1,695,000 | +301.7% | 39,396 | +559.5% | 0.01% | +550.0% |
| Q2 2015 | $422,000 | +58.1% | 5,974 | +99.0% | 0.00% | 0.0% |
| Q1 2015 | $267,000 | -48.7% | 3,002 | -48.9% | 0.00% | 0.0% |
| Q4 2014 | $520,000 | +88.4% | 5,870 | +106.0% | 0.00% | 0.0% |
| Q3 2014 | $276,000 | +4.2% | 2,849 | -1.1% | 0.00% | 0.0% |
| Q2 2014 | $265,000 | – | 2,882 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |